These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8992128)
1. [Drug consumption in diabetes mellitus (V). Pharmacoeconomics and the acceptance of the hospital changeover to insulin U100. Group for the Study of Diabetes in Tarragona]. Costa B; Estopá A; Borrás J; Sabaté A; Páez F Med Clin (Barc); 1996 Apr; 106(13):481-5. PubMed ID: 8992128 [TBL] [Abstract][Full Text] [Related]
2. [Consumption of drugs in diabetes mellitus II. Utilization and loss of insulin: epidemiologic and socioeconomic implications. Study Group for Diabetes in Tarragona (GEDT)]. Costa B; Monclús JF; Huguet M Med Clin (Barc); 1993 Feb; 100(7):241-4. PubMed ID: 8433583 [TBL] [Abstract][Full Text] [Related]
3. [The changeover to insulin U100. Clinical and pharmacoeconomic suggestions]. Costa B Med Clin (Barc); 1996 Apr; 106(13):495-7. PubMed ID: 8992131 [No Abstract] [Full Text] [Related]
4. [Diabetes and pharmacoeconomics. Efficiency of insulin injection methods available in Spain]. Costa B; Estopá A; Borrás J; Sabaté A Aten Primaria; 1995 Oct; 16(7):391-6. PubMed ID: 7495947 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin. Heinemann L; Chantelau EA; Starke AA Diabete Metab; 1992; 18(1):21-4. PubMed ID: 1563532 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp. Heinemann L; Weyer C; Rave K; Stiefelhagen O; Rauhaus M; Heise T Exp Clin Endocrinol Diabetes; 1997; 105(3):140-4. PubMed ID: 9228509 [TBL] [Abstract][Full Text] [Related]
8. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)]. Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091 [TBL] [Abstract][Full Text] [Related]
9. Accuracy and precision of low-dose insulin administration. Casella SJ; Mongilio MK; Plotnick LP; Hesterberg MP; Long CA Pediatrics; 1993 Jun; 91(6):1155-7. PubMed ID: 8502520 [TBL] [Abstract][Full Text] [Related]
10. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study]. von Ferber L; Köster I; Hauner H Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485 [TBL] [Abstract][Full Text] [Related]
11. [Drug consumption in diabetes mellitus (III). Trends of hypoglycemic agents use and consumption in Tarragona, Catalonia, and Spain (1988- 1991). Group for the Study of Diabetes in Tarragona]. Costa B; Hernández JM Med Clin (Barc); 1993 Apr; 100(15):571-5. PubMed ID: 8497145 [TBL] [Abstract][Full Text] [Related]
12. Identifying factors that affect patients' willingness to pay for inhaled insulin. Pinto SL; Holiday-Goodman M; Black CD; Lesch D Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826 [TBL] [Abstract][Full Text] [Related]
13. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391 [TBL] [Abstract][Full Text] [Related]
14. [Drug consumption in diabetes mellitus (I). Estimate of the therapeutic profile and the prevalence in the regions of Tarragona (548,900 inhabitants). Grup per a l'Estudi de la Diabetis a Tarragona]. Costa B; Utgés P; Monclús JF; Gomis T; Ciurana MR; Julve P Med Clin (Barc); 1992 Sep; 99(8):294-9. PubMed ID: 1453822 [TBL] [Abstract][Full Text] [Related]
15. Preference for insulin delivery systems among current insulin users and nonusers. Summers KH; Szeinbach SL; Lenox SM Clin Ther; 2004 Sep; 26(9):1498-505. PubMed ID: 15531012 [TBL] [Abstract][Full Text] [Related]
16. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes. Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585 [TBL] [Abstract][Full Text] [Related]
17. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128 [TBL] [Abstract][Full Text] [Related]
18. U100 insulin and the general practitioner. Hartman LJ Aust Fam Physician; 1980 Jul; 9(7):464-8. PubMed ID: 6998449 [TBL] [Abstract][Full Text] [Related]
19. [Impact of diabetes mellitus on hospitalization costs]. Pascual JM; González C; de Juan S; Sánchez C; Sánchez B; Pérez M Med Clin (Barc); 1996 Jul; 107(6):207-10. PubMed ID: 8755447 [TBL] [Abstract][Full Text] [Related]
20. Multiple reuse of disposable insulin syringes in hospital. Islam MS; Ali SM Bangladesh Med Res Counc Bull; 1990 Dec; 16(2):58-61. PubMed ID: 2096812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]